These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 32367193)

  • 41. CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis.
    Saluzzo F; Riberi L; Messore B; Loré NI; Esposito I; Bignamini E; De Rose V
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.
    Mickle JE; Cutting GR
    Clin Chest Med; 1998 Sep; 19(3):443-58, v. PubMed ID: 9759548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation.
    Ferrari E; Monzani R; Villella VR; Esposito S; Saluzzo F; Rossin F; D'Eletto M; Tosco A; De Gregorio F; Izzo V; Maiuri MC; Kroemer G; Raia V; Maiuri L
    Cell Death Dis; 2017 Jan; 8(1):e2544. PubMed ID: 28079883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Potential Causes of Cystic Fibrosis-Related Diabetes.
    Coderre L; Debieche L; Plourde J; Rabasa-Lhoret R; Lesage S
    Front Endocrinol (Lausanne); 2021; 12():702823. PubMed ID: 34394004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
    Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
    J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis.
    Jung H; Ki CS; Koh WJ; Ahn KM; Lee SI; Kim JH; Ko JS; Seo JK; Cha SI; Lee ES; Kim JW
    Korean J Lab Med; 2011 Jul; 31(3):219-24. PubMed ID: 21779199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator.
    Phennicie RT; Sullivan MJ; Singer JT; Yoder JA; Kim CH
    Infect Immun; 2010 Nov; 78(11):4542-50. PubMed ID: 20732993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apoptotic process in cystic fibrosis cells.
    Soleti R; Porro C; Martínez MC
    Apoptosis; 2013 Sep; 18(9):1029-38. PubMed ID: 23793868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrative expression analysis identifies a novel interplay between CFTR and linc-SUMF1-2 that involves CF-associated gene dysregulation.
    Kamei S; Maruta K; Fujikawa H; Nohara H; Ueno-Shuto K; Tasaki Y; Nakashima R; Kawakami T; Eto Y; Suico MA; Suzuki S; Gruenert DC; Li JD; Kai H; Shuto T
    Biochem Biophys Res Commun; 2019 Feb; 509(2):521-528. PubMed ID: 30598261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Applicability of different antibodies for immunohistochemical localization of CFTR in sweat glands from healthy controls and from patients with cystic fibrosis.
    Claass A; Sommer M; de Jonge H; Kälin N; Tümmler B
    J Histochem Cytochem; 2000 Jun; 48(6):831-7. PubMed ID: 10820156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myeloid CFTR loss-of-function causes persistent neutrophilic inflammation in cystic fibrosis.
    Ng HP; Jennings S; Wellems D; Sun F; Xu J; Nauseef WM; Wang G
    J Leukoc Biol; 2020 Dec; 108(6):1777-1785. PubMed ID: 32531843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Early bronchial inflammation in cystic fibrosis].
    Puchelle E
    J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The L441P mutation of cystic fibrosis transmembrane conductance regulator and its molecular pathogenic mechanisms in a Korean patient with cystic fibrosis.
    Gee HY; Kim CK; Kim SW; Lee JH; Kim JH; Kim KH; Lee MG
    J Korean Med Sci; 2010 Jan; 25(1):166-71. PubMed ID: 20052366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A foetus with cystic fibrosis - To treat or not to treat?
    Padmakumar N; Khan HS
    Respir Med Res; 2023 Jun; 83():101006. PubMed ID: 37037055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.
    Belcher CN; Vij N
    Curr Mol Med; 2010 Feb; 10(1):82-94. PubMed ID: 20205681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutational spectrum of CFTR in cystic fibrosis patients with gastrointestinal and hepatobiliary manifestations.
    Waheed N; Waris R; Naseer M; Razzaq A; Haider N; Shah AA; Ullah A
    Mol Biol Rep; 2024 Apr; 51(1):573. PubMed ID: 38662334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular complications in cystic fibrosis: A review of the literature.
    Poore TS; Taylor-Cousar JL; Zemanick ET
    J Cyst Fibros; 2022 Jan; 21(1):18-25. PubMed ID: 34140249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-talk between CFTR and sphingolipids in cystic fibrosis.
    Dobi D; Loberto N; Bassi R; Pistocchi A; Lunghi G; Tamanini A; Aureli M
    FEBS Open Bio; 2023 Sep; 13(9):1601-1614. PubMed ID: 37315117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.